Viewing Study NCT01887795


Ignite Creation Date: 2025-12-24 @ 2:04 PM
Ignite Modification Date: 2026-02-23 @ 8:08 PM
Study NCT ID: NCT01887795
Status: COMPLETED
Last Update Posted: 2016-08-25
First Post: 2013-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module